A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to contrast the efficacy and safety of 3 dose levels of
nebivolol vs. placebo, when added to a patient's existing antihypertensive medication(s) for
3 months, in patients with mild to moderate hypertension